Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Ferroptosis

FSP1 inhibition: pick your pocket

Subjects

Ferroptosis suppressor protein 1 (FSP1, or AIFM2), an NADPH quinone reductase noted to protect cancer cells from ferroptosis, acts in FAD/NADPH binding and proton transfer. Recent papers assess its evolutionarily conserved sites via mutagenesis and define its inhibition as an off-target mediator of brequinar-mediated ferroptosis sensitization.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematic of FSP1 inhibitor modes-of-action.

References

  1. Dixon, S. J. et al. Cell 149, 1060–1072 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Viswanathan, V. S. et al. Nature 547, 453–457 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hangauer, M. J. et al. Nature 551, 247–250 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Doll, S. et al. Nature 149, 1060–20 (2019).

    Google Scholar 

  5. Bersuker, K. et al. Nature 575, 688–692 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mishima, E. et al. Nature 608, 778–783 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhang, S. et al. Cell Res. https://doi.org/10.1038/s41422-023-00879-z (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Müller, F. et al. Cell Death Differ. 30, 442–456 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Koppula, P. et al. Nat. Commun. 13, 2206 (2022).

    Article  CAS  PubMed Central  Google Scholar 

  10. Nakamura, T. et al. Nature 619, 371–377 (2023).

    Article  CAS  PubMed Central  Google Scholar 

  11. Nakamura, T. et al. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-023-01136-y (2023).

    Article  Google Scholar 

  12. Mishima, E. et al. Nature 619, E9–E18 (2023).

    Article  CAS  PubMed  Google Scholar 

  13. Mao, C. et al. Nature 593, 586–590 (2021). Cell Death Dis. 14, 1–9 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Xavier da Silva, T. N., Schulte, C., Alves, A. N., Maric, H. M. & Friedmann Angeli, J. P. Cell Death Dis 14, 1–9 (2023).

  15. Hendricks, J. M. et al. Cell Chem. Biol. 30, 1090–1103.e7 (2023).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

S.v.K. receives funding from collaborative research center grants (SFB1403, ID 414786233; SFB1530, ID 455784452; SFB1399, ID 413326622 and SFB1310, ID 325931972), through a priority program on ferroptosis (SPP2306, ID 461704389) all funded by the German Research Foundation (Deutsche Forschungsgesellschaft, DFG), and via CANTAR, which is funded through the program Netzwerke 2021, an initiative of the Ministry of Culture and Science of the State of Northrhine Westphalia, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia von Karstedt.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bebber, C.M., von Karstedt, S. FSP1 inhibition: pick your pocket. Nat Struct Mol Biol 30, 1618–1619 (2023). https://doi.org/10.1038/s41594-023-01145-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41594-023-01145-x

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer